Related Experiment Videos

Construction and characterization of ciliary neurotrophic factor (CNTF) antagonists: microenvironmental difference in

M Inoue1, H Karita, C Nakayama

  • 1Sumitomo Pharmaceuticals Research Center, Konohana-ku, Osaka, Japan.

Insights

Engineered ciliary neurotrophic factor (CNTF) mutants show antagonistic properties, inhibiting neuronal survival. Specific mutations reveal differences in chicken versus rat receptor binding, impacting therapeutic potential.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Protein Engineering

Background:

  • Ciliary neurotrophic factor (CNTF) is crucial for neuronal survival.
  • Understanding CNTF-receptor interactions is key for developing targeted therapies.
  • Previous studies have not fully elucidated the role of specific residues in CNTF's activity.

Purpose of the Study:

  • To construct and characterize antagonistic mutants of CNTF.
  • To investigate the differential receptor recognition between chicken and rat neurons.
  • To identify key residues and interactions involved in CNTF's biological activity.

Main Methods:

  • Site-directed mutagenesis was used to create K155A, K155W, F152S/K155A, and F152D/K155A CNTF mutants.
  • Cell survival assays were performed using chicken and rat dorsal root ganglion (DRG) neurons.
  • Structural analysis of CNTF was used to infer binding interactions.

Main Results:

  • K155A and K155W mutants lost chicken DRG neuron survival activity and inhibited wild-type CNTF.
  • These mutants retained slight agonistic activity on rat DRG neurons, suggesting species-specific receptor recognition.
  • Combined mutations (F152S/K155A, F152D/K155A) rendered CNTF antagonistic to both chicken and rat DRG neurons.
  • Structural analysis indicated F152 and K155 are critical for receptor binding via hydrophobic and electrostatic interactions, respectively.

Conclusions:

  • The D1 cap region, including residues F152 and K155, plays a critical role in CNTF receptor binding.
  • Chicken CNTF receptors exhibit stricter recognition of the D1 cap region compared to rat receptors.
  • Engineered antagonistic CNTF mutants offer potential tools for studying neurotrophic factor signaling and developing novel therapeutics.

Related Concept Videos